Analytical Data
-
Gene name
FSTL3
- Application
-
Alternative Names
FSTL3；FLRG；Follistatin-related Protein 3
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95633
-
Expression Region
27-263aa
-
AA Sequence
MGSG NPAPGGVCWL QQGQEATCSL VLQTDVTRAE CCASGNIDTA WSNLTHPGNK INLLGFLGLV HCLPCKDSCD GVECGPGKAC RMLGGRPRCE CAPDCSGLPA RLQVCGSDGA TYRDECELRA ARCRGHPDLS VMYRGRCRKS CEHVVCPRPQ SCVVDQTGSA HCVVCRAAPC PVPSSPGQEL CGNNNVTYIS SCHMRQATCF LGRSIGVRHA GSCAGTPEEP PGGESAEEEE NFV
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FSTL3, or Follistatin-like 3, is a member of the Follistatin family of proteins, which play crucial roles in various biological processes, including tissue development, cellular differentiation, and inflammatory responses. Research has shown that FSTL3 is implicated in several pathological conditions, such as obesity, diabetes, and cardiovascular diseases, making it a protein of significant interest in the field of biomedical research. Its involvement in modulating signaling pathways, particularly those related to transforming growth factor-beta (TGF-β) superfamily members, further emphasizes its potential as a therapeutic target. The study of FSTL3 recombinant proteins aims to elucidate its functional mechanisms, interactions with other proteins, and its role in disease states. Understanding the structure and function of FSTL3 can facilitate the development of novel therapies, including those aimed at ameliorating metabolic disorders and inflammatory diseases. Advanced techniques such as recombinant DNA technology and protein purification are employed to produce FSTL3 protein in sufficient quantities for experimental analysis. By characterizing the biochemical properties and biological activities of FSTL3, researchers hope to establish its role as a biomarker for disease progression and treatment response, ultimately contributing to personalized medicine approaches in treating related health issues.
